ATRC (Medical devices) Stock Valuation & Fair Value
Significantly overvaluedATRC (Medical devices) trades at a current P/E of 1,211.7, far above its historical normal valuation, with a forward growth estimate above 100% and a PEG of 5.32. Analysts' one-year estimates have been hit 36% of the time.
How to read these numbers: the PEG ratio and current P/E versus normal P/E.
Valuation flags
- Overvalued far beyond its normal P/E
- High PEG (5.3x)
- Misses analyst estimates often (55%)
Frequently asked questions
Is ATRC overvalued?
At a current P/E of 1,211.7 versus its historical normal P/E of 63.8, ATRC trades far above its typical valuation, with a PEG of 5.32 on forward growth above 100%. tickerseer currently rates it significantly overvalued.
What is ATRC's fair value and PEG?
ATRC trades at a current P/E of 1,211.7 against a historical normal P/E of 63.8, a PEG of 5.32, and a forward growth estimate above 100%.
Has tickerseer's rating of ATRC changed?
tickerseer's rating has been significantly overvalued since 2026-10-31.
Industry: Medical devices. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and an AI research note where we have one. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.
It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.